The scientific context and basis of the pharmacologic management of dry eyes.
The ability to diagnose and treat dry eye has improved dramatically over the last decade as understanding of disease mechanisms and pathology has improved. The ability to screen patients for dry eye before ophthalmic plastics procedures has improved, and the ability to manage and treat dry eye in patients after surgery also has improved.
Gilbard
Jeffrey P
JP
Department of Ophthalmology, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA. jgilbard@theratears.com
D015352:Dry Eye Syndromes / Q000188:drug therapy* / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D009883:Ophthalmic Solutions; D013666:Tears / Q000187:drug effects / Q000378:metabolism; D013754:Tetracyclines / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D009883:Ophthalmic Solutions; D013754:Tetracyclines